Published online December 17, 2007
PEDIATRICS Vol. 121 No. 1 January 2008, pp. e141-e145 (doi:10.1542/peds.2007-1319)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benoit, M. M.
Right arrow Articles by Cunningham, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benoit, M. M.
Right arrow Articles by Cunningham, M.
Related Collections
Right arrow Tumors
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Cancer of the Nasal Cavity in the Pediatric Population

Margo McKenna Benoit, MDa,b, Neil Bhattacharyya, MD, FACSb,c, William Faquin, MDd and Michael Cunningham, MD, FACS, FAAPa,b

a Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
b Department of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts
c Division of Otolaryngology, Brigham and Women's Hospital, Boston, Massachusetts
d Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts

OBJECTIVE. The purpose of this work was to investigate the clinical manifestations and diagnostic range of malignant entities presenting as a nasal mass in the pediatric population.

PATIENTS AND METHODS. A retrospective cohort analysis was conducted at a specialty hospital and a tertiary care university hospital. Patients aged between birth and 18 years and diagnosed with a malignancy that arose within the nasal cavity between the years 1991 and 2006 were included. This institution-specific patient group was compared with a similar cohort of patients extracted from the national Surveillance Epidemiology and End Results database. The main outcome measures were the incidence, presentation, and diagnoses of nasal cancer presenting in this population.

RESULTS. Sixteen patients with nasal malignancies presented institutionally in the defined pediatric age group. Patient age at the time of diagnosis ranged from 7 months to 17 years, with a slight male predominance. The main presenting symptoms were unilateral nasal congestion and ophthalmologic complaints. The median time from presentation to diagnosis was 7 weeks; patients who presented with nonspecific complaints, such as nasal obstruction, headache, and fatigue, were given a diagnosis, on average, later than those who presented with focal manifestations. Nationwide, 47 patients were identified from the Surveillance Epidemiology and End Results database. In both subject groups, the most common diagnoses were rhabdomyosarcoma (37.5% institutionally and 23% in the Surveillance Epidemiology and End Results group) and esthesioneuroblastoma (25% institutionally and 28% Surveillance Epidemiology and End Results). In the Surveillance Epidemiology and End Results cohort, the overall mean survival rate was 188 months.

CONCLUSIONS. Nasal cancer in the pediatric population often presents with nonspecific signs and symptoms, and a high index of suspicion is necessary for a timely diagnosis. Soft tissue sarcomas are expectedly common. The relative high frequency of esthesioneuroblastoma is particularly noteworthy.

Key Words: esthesioneuroblastoma • rhabdomyosarcoma • nasal obstruction • neoplasm

Abbreviations: MGH—Massachusetts General Hospital • SEER—Surveillance Epidemiology and End Results • PNET—primitive neuroectodermal tumor • AJCC—American Joint Commission on Cancer • ACR—anterior craniofacial resection

Accepted Jun 6, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch Otolaryngol Head Neck SurgHome page
Pathology Quiz Case 2: Diagnosis
Arch Otolaryngol Head Neck Surg, September 1, 2009; 135(9): 947 - 948.
[Full Text] [PDF]